Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Daiichi Sankyo Shutters Yet Another R&D Facility February 9, 2017 <b>Elligo Health Research</b> Names <b>Deirdre BeVard</b> As Chief Operating Officer August 29, 2017 Future Biotech Giants: 11 Life Science Entrepreneurs Under 30 February 22, 2017
